Mike Ashley wins trademark appeal, throwing out eye-watering damages bill May 12, 2026 The retail empire of business tycoon Mike Ashley has won an appeal challenging damages awarded in a trademark infringement claim, sidestepping paying a potentially stinging bill. The judgment follows a longstanding legal dispute between the discount sports retailer and the Beverly Hills Polo Club brand, owned and managed by Lifestyle Equities, which argued Ashley’s Sports [...]
Starmer to nationalise British Steel in bid to save premiership May 11, 2026 Keir Starmer has promised to nationalise British Steel and prioritise closer ties with the European Union in a make or break speech to save his premiership after a bruising set of local election results. Speaking after a weekend of frenzied speculation on his future in Number 10 Downing Street, the Prime Minister rejected calls for [...]
Mike Ashley: I was behind Peter Cowgill’s JD Sports downfall May 10, 2026 Billionaire businessman Mike Ashley has admitted he masterminded the infamous car park footage leak that brought down his arch rival, JD Sports’ boss Peter Cowgill. Cowgill, who was executive chairman of JD Sports, quit the sportswear retailer in 2022 after being fined by the competition watchdog over a car park rendezvous with the boss of [...]
Time to network the rail May 7, 2026 Five London stations are being redeveloped – let’s combine these projects to get London’s growth back on track, says Peter Hogg Railway stations define London. From the first family trip out of Euston to the countryside, to passing through the market at King’s Cross, for many Londoners they are as integral to life here as [...]
City watchdog probes Mastercard, Visa, Paypal for alleged anti-competitive conduct May 6, 2026 The City watchdog has confirmed it is investigating a trio of payments giants over alleged anti-competitive conduct. The Financial Conduct Authority (FCA) will probe Mastercard, Paypal and Visa under the Competition Act 1998 regarding its suspected conduct related to the “funding and usage” of Paypal’s digital wallet. Paypal’s digital wallet is an app-based system that [...]
Supermarkets round on Aldi and Lidl over ‘rigged’ system May 6, 2026 A host of leading British supermarkets have rounded on German discounters Aldi and Lidl over fears competition is being “distorted” by a “rigged” system. Sainsbury’s, Morrisons and Iceland are ramping up pressure on the competition watchdog to crack down on Aldi and Lidl’s ability to block rivals from opening new stores on nearby land. The [...]
IGI Reports First Quarter of 2026 Unaudited Financial Results May 5, 2026 International General Insurance Holdings Ltd. (“IGI” or the “Company”) (NASDAQ: IGIC) today reported financial results for the first quarter of 2026. Highlights for the first quarter of 2026 include: (in millions of U.S. Dollars, except percentages and per share information) Quarter Ended March 31, 2026 2025 Gross written premiums $197.2 $206.5 Net premiums [...]
Petrol retailers vindicated after Reeves ‘profiteering’ claims May 1, 2026 Petrol retailers have been vindicated of “price gouging”, pouring cold water on the government’s accusations of profiteering from the war in Iran. The Competition and Markets Authority (CMA) found that higher fuel prices in the UK were caused by the rising cost of oil, rather than by retailers expanding their margins to profit from the [...]
Everest Reports First Quarter 2026 Results April 29, 2026 Annualized 16.8% Net Income ROE and 16.7% Net Operating Income ROE $316 million of Underwriting Income and Combined Ratio of 91.2% Repurchased $331 million of Common Shares During the Quarter
European Commission (EC) Approves Henlius and Organon’s POHERDY® (pertuzumab), the First Approved Biosimilar to PERJETA (pertuzumab) in Europe April 29, 2026 Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced the European Commission (EC) has granted marketing authorization for POHERDY® (pertuzumab) 420 mg/14 mL injection for intravenous use, the first and only approved biosimilar to PERJETA (pertuzumab) in Europe, for all indications of the reference product.1 This press release features multimedia. View the full [...]